EXACT SCIENCES CORP (EXAS) — SEC Filings

Latest SEC filings for EXACT SCIENCES CORP (EXAS), explained in plain English.

Sentiment Overview: 1 bullish, 1 bearish, 30 neutral

Recent Filings (32)

• Exact Sciences Terminates SEC Registration — 15-12G · 2026-04-02T06:06:01-04:00 [neutral] Risk: low
  Exact Sciences Corp. filed a Form 15-12G on April 2, 2026, to terminate the registration of its securities under Section 12(g) of the Securities Exchange Act. T
• DEFA14A Filing — DEFA14A · 2025-12-29T00:00:00.000Z [neutral]
• DEFA14A Filing — DEFA14A · 2025-11-26T00:00:00.000Z [neutral]
• Exact Sciences Corp. Proxy Filing — DEFA14A · 2025-11-24T00:00:00.000Z [neutral] Risk: low
  Exact Sciences Corp. filed a DEFA14A on November 24, 2025, related to soliciting material sent to employees on November 21, 2025. The email, from Kevin Conroy,
• 8-K Filing — 8-K · 2025-11-20T00:00:00.000Z [neutral]
• Exact Sciences Narrows Q3 Loss on Strong Revenue Growth — 10-Q · 2025-11-03T00:00:00.000Z [bullish] Risk: medium
  EXACT SCIENCES CORP (EXAS) reported a net loss of $19.594 million for the three months ended September 30, 2025, a significant improvement from the $38.236 mill
• Exact Sciences Q2 Loss Widens to $100M Despite 15% Revenue Jump — 10-Q · 2025-08-06T00:00:00.000Z [bearish] Risk: medium
  EXACT SCIENCES CORP reported a net loss of $100.0 million for the three months ended June 30, 2025, a significant increase from the net loss of $75.0 million fo
• Exact Sciences Corp. Files 8-K with Board and Compensation Updates — 8-K · 2025-06-16T00:00:00.000Z [neutral] Risk: medium
  Exact Sciences Corp. announced on June 12, 2025, changes in its board of directors and executive compensation arrangements. The filing also covers the submissio
• Exact Sciences Corp. Files Q1 2025 10-Q — 10-Q · 2025-05-01T00:00:00.000Z [neutral] Risk: medium
  Exact Sciences Corp. reported its first quarter 2025 results, ending March 31, 2025. The company's filing details its financial position and operational perform
• Exact Sciences Corp. Reports Board and Executive Compensation Changes — 8-K · 2025-04-29T00:00:00.000Z [neutral] Risk: low
  Exact Sciences Corp. announced on April 29, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of
• Exact Sciences Corp. Files 2024 10-K — 10-K · 2025-02-19T00:00:00.000Z [neutral] Risk: medium
  Exact Sciences Corp. filed its 2024 10-K on February 19, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, he
• Exact Sciences Corp. Files 8-K on Material Definitive Agreement — 8-K · 2025-01-13T00:00:00.000Z [neutral] Risk: medium
  Exact Sciences Corp. entered into a material definitive agreement on January 12, 2025, related to financial obligations. The company, incorporated in Delaware w
• Exact Sciences Elects New Directors, Adjusts CMO Compensation — 8-K · 2025-01-06T00:00:00.000Z [neutral] Risk: low
  Exact Sciences Corp. announced on January 2, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new direc
• SC 13G Filing — SC 13G · 2024-11-13T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-11-08T00:00:00.000Z [neutral]
• Exact Sciences Files Q3 2024 10-Q — 10-Q · 2024-11-05T00:00:00.000Z [neutral] Risk: medium
  Exact Sciences Corp. reported its third-quarter 2024 results, with the filing dated November 5, 2024. The company's fiscal year ends on December 31st. Key finan
• SC 13G Filing — SC 13G · 2024-10-07T00:00:00.000Z [neutral]
• SC 13G Filing — SC 13G · 2024-10-04T00:00:00.000Z [neutral]
• Exact Sciences Corp. Files Q2 2024 10-Q — 10-Q · 2024-07-31T00:00:00.000Z [neutral] Risk: low
  Exact Sciences Corp. reported its financial results for the period ending June 30, 2024. The company's filing provides details on its financial position and per
• Exact Sciences Files 8-K on Shareholder Votes and Financials — 8-K · 2024-06-17T00:00:00.000Z [neutral] Risk: low
  Exact Sciences Corporation filed an 8-K on June 17, 2024, reporting on matters submitted to a vote of security holders and financial statements as of June 13, 2
• SC 13G/A Filing — SC 13G/A · 2024-06-07T00:00:00.000Z [neutral]
• Exact Sciences Appoints New CFO, Boyer — 8-K · 2024-06-03T00:00:00.000Z [neutral] Risk: medium
  Exact Sciences Corp. announced on May 30, 2024, the appointment of Dr. Jeffrey S. Boyer as Chief Financial Officer, effective June 3, 2024. Dr. Boyer previously
• Exact Sciences Corp. Files Q1 2024 10-Q Report — 10-Q · 2024-05-08T00:00:00.000Z [neutral] Risk: low
  Exact Sciences Corp. reported its first quarter 2024 results, ending March 31, 2024. The company's filing details its financial position and operational perform
• Exact Sciences Corp. Reports Board Changes and Compensation Updates — 8-K · 2024-04-25T00:00:00.000Z [neutral] Risk: low
  Exact Sciences Corp. announced on April 25, 2024, changes in its board of directors and executive compensation. The filing details the departure of certain offi
• Exact Sciences Files 8-K: Material Agreement & Equity Sales — 8-K · 2024-04-17T00:00:00.000Z [neutral] Risk: medium
  Exact Sciences Corp. entered into a material definitive agreement on April 17, 2024, related to a direct financial obligation. The company also reported on unre
• Exact Sciences Appoints New Chief Legal Officer — 8-K · 2024-04-15T00:00:00.000Z [neutral] Risk: low
  Exact Sciences Corp. announced on April 15, 2024, the appointment of Paul J. D. Radin as its new Chief Legal Officer. Radin previously served as Senior Vice Pre
• Exact Sciences Files 10-K, Details 2023 Financials — 10-K · 2024-02-21T00:00:00.000Z [neutral] Risk: medium
  EXACT SCIENCES CORP (EXAS) filed its 10-K on February 21, 2024, for the fiscal year ending December 31, 2023. The company, a medical laboratories service provid
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• Wellington Management Group LLP Amends EXACT SCIENCES Corp. Stake — SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
  Wellington Management Group LLP, a major investment firm, filed an amended SC 13G/A on February 9, 2024, disclosing its ownership of EXACT SCIENCES CORP (EXAS)
• BlackRock Amends EXACT SCIENCES CORP Stake as of Dec 31, 2023 — SC 13G/A · 2024-01-29T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating a change in their ownership of EXACT SCIENCES CORP's common stock as of December 31, 20
• JPMorgan Amends Exact Sciences Stake as of Dec 29, 2023 — SC 13G/A · 2024-01-23T00:00:00.000Z [neutral]
  JPMorgan Chase & Co. filed an amended Schedule 13G/A on January 23, 2024, indicating a change in their beneficial ownership of Exact Sciences Corp. common stock
• EXACT SCIENCES Files 8-K on Operations & Officer Arrangements — 8-K · 2024-01-08T00:00:00.000Z [neutral]
  EXACT SCIENCES CORP filed an 8-K on January 7, 2024, to report on its financial condition and operations, specifically regarding the departure or appointment of